RENAGEL 400 Pill - white oval, 15mm
Generic Name: sevelamer
Pill with imprint RENAGEL 400 is White, Oval and has been identified as Renagel 400 mg. It is supplied by Genzyme.
Renagel is used in the treatment of Hyperphosphatemia of Renal Failure and belongs to the drug class phosphate binders. Risk cannot be ruled out during pregnancy. Renagel 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RENAGEL 400
Renagel
- Generic Name
- sevelamer
- Imprint
- RENAGEL 400
- Strength
- 400 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Phosphate binders
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genzyme
- National Drug Code (NDC)
- 58468-0020 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
propylene glycol,
isopropyl alcohol
Note: Inactive ingredients may vary.
See also:
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Ibsrela
Ibsrela (tenapanor) is used for the treatment of irritable bowel syndrome with constipation ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Velphoro
Velphoro (sucroferric oxyhydroxide) is used to treat hyperphosphatemia in chronic kidney disease ...
Xphozah
Xphozah (tenapanor) is a phosphate absorption inhibitor that is used lower serum phosphorus levels ...
More about Renagel (sevelamer)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: phosphate binders
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.